AI Gold Rush: Who Wins The Battle For Compute, Capital And Open-Source Dominance?
The rise of DeepSeek’s cost-efficient AI models is challenging the dominance of high-cost, proprietary AI systems, ...
Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003
Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...